Communication, Education, and Training Flashcards
Discuss regulatory guidance: FDA Medical Device Reporting regulations.
The FDA Medical Device Reporting regulations, which are part of the Safe Medical Devices Act (1990), periodically revised, require that user facilities that receive reports of malfunction of medical devices, serious injury, or death associated with their use must report these incidents.
Serious injury is one that is
1) life-threatening,
(2) results in permanent impairment or damage, or
(3) requires medical or surgical intervention to prevent permanent impairment or damage.
Deaths must be reported to both the FDA and the manufacturer and serious injuries to the manufacturer within 10 days of discovery (FDA form 1050).
Manufacturers receiving a 10-day report must obtain further information if possible and then file the report with the FDA. An annual report (FDA form 3419) that includes all incidents (deaths, serious injuries) that occurred during the calendar year must be submitted to the FDA. Users are also required to track medical devices that pose a potential risk to the patient if they malfunction. User facilities do not include physicians’ offices but do include ambulatory care centers, hospitals, nursing homes, rehab centers, home health agencies, blood banks, ambulance services, rescue services, outpatient treatment facilities, diagnostic centers, dialysis centers, and psychiatric facilities.
User facilities must maintain medical device reporting event files and maintain these files for two years.
Discuss regulatory guidance
Healthcare-associated infection.
Healthcare-associated infection (HAI) is a localized or systemic infection that occurs 48 hours (beginning with day 3) or more after admission to a healthcare facility because of an adverse reaction to a pathogenic agent or toxin. An infection may be classified as healthcare-associated if it is evident within 48 hours of admission and the patient had contact with healthcare providers at some point in the previous year. According to the CDC, the types of HAI include central line-associated bloodstream infection (CLABSI), ventilator-associated pneumonia (VAP), catheter-associated urinary tract infection (CAUTI), and surgical site infection (SSI). CMS requires that healthcare providers report HAI’s at the federal level, and more than half of the states require some reporting of HAIs, but the specific requirements vary by state with some requiring only reporting of MRSA infections and others requiring
reporting of all types of HAIs.
Discuss regulatory guidance
CMS’s Quality Assessment and Performance Improvement (QAPI) rule (42 CFR 482.21) for hospitals.
The Centers for Disease Control and Prevention (CDC) publishes an annual Quality Assessment and Performance Improvement (QAPI) rule requiring hospitals and nursing homes to develop and maintain quality improvement programs involving all departments to reduce incidence of medical errors. The entity must be able to provide evidence of quality improvement if under CMS review.
Program elements for hospitals must include:
- Ensuring an ongoing comprehensive program addressing all aspects of care and showing measurable improvement in selected indicators. Hospitals must measure, assess, and monitor quality indicators and adverse patient events.
- Using data to monitor the effectiveness of patient care and services and to develop program improvement plans.
- Setting priorities for PI activities that focus on high-risk areas. PI activities must monitor and assess medical errors and adverse events, implement preventive actions, and provide feedback and education.
- Establishing PI projects on a scale appropriate for the size and scope of the organization.
-
Ensuring the board, administration, and medical staff account for and are responsible for:
- (1) Ongoing PI program,
- (2) Hospital-wide QAPI’ efforts addressing priorities and evaluations,
- (3) Patient safety expectations,
- (4) Provision of adequate resources, and
- (5) Annual assessment of QAPI programs.
Discuss regulatory guidance:
Notifiable disease surveillance (CDC)
The Centers for Disease Control and Prevention (CDC) publishes an annual list of notifiable diseases, which may include infectious diseases (such as syphilis and brucellosis), non-infectious conditions (cancer, lead exposure, pesticide-related illness/injury, carbon monoxide poisoning, and silicosis), and outbreaks (foodborne and waterborne). States and local public health departments may require additional reporting. HIPAA allows PHI to be shared for public health reporting without consent. The general steps that
occur when a patient is diagnosed with a notifiable condition include:
- Confirming the diagnosis: Physician examination, laboratory testing.
- Reporting findings: Reports are usually sent to local or state public health departments. Specific forms may be required for reporting and time limits (such as within 24 hours) may be required.
- Reporting to CDC: State public health review the reports and when appropriate the report is sent by the state public health department to the CDC.
- Collecting and analyzing: The National Notifiable Diseases Surveillance System Team collects and analyzes the reports and sends data to the appropriate program at the CDC.
- Evaluating outbreaks, disease patterns: The CDC looks for disease patterns or outbreaks and determines if assistance is needed in outbreak research and containment.
Discuss regulatory guidance:
CMS’s Quality Assessment and Performance Improvement (QAPI) rule (42 CFR 482.21) for nursing homes
5 elements
Present on admission: POA refers to an infection that meets the CMS’s Quality Assessment and Performance Improvement (QAPI)
criteria for site-specific symptoms and diagnosis and is evident two days rule (42 CFR 482.21) for nursing homes must include 5 elements:
prior to admission to a healthcare facility, the day of admission (day 1) 1. Design and scope: Program must be comprehensive and ongoing,
or the next day (day 2). Physician’s diagnosis alone is not adequate aiming for patient safety and high-quality care while supporting
without evidence (documented) of symptoms and/or laboratory patient autonomy and choices.
confirmation as required for the specific type of infection. Governance and leadership: Governing board should provide
adequate resources for QAPI efforts, designate one or more persons
Transfer rule: The transfer rule helps to determine responsibility for to be responsible for QAPI, and ensure time, equipment, and
infections. If an infection meets the site-specific criteria on the day of training needed. The board should establish a culture of quality and
transfer or the day after transfer from one inpatient facility to another safety.
inpatient within the same facility or another, or the day of discharge or Feedback, data systems and monitoring: The home collects data,
the day after discharge, the infection is attributed to the monitors services using performance indicators, and reviews
transferring/discharging facility. findings. All adverse events must be investigated when they occur
and action plans implemented.
80% rule: A patient care area is designated according to the type of 4. Performance improvement projects (PIPs): PIPS should be
patient. If 80% of the patients are of a specific type (such as oncology developed to improve care and services.
patients), the CDC location code designates the area accordingly. Systematic analysis and systemic action: The organization
carries out analysis utilizing a structured approach and root cause
analysis with a focus on continuous improvement.
Define the following terms: Present on admission, transfer rule, 80% rule.
Present on admission: POA refers to an infection that meets the CMS’s Quality Assessment and Performance Improvement (QAPI)
criteria for site-specific symptoms and diagnosis and is evident two days rule (42 CFR 482.21) for nursing homes must include 5 elements:
prior to admission to a healthcare facility, the day of admission (day 1) 1. Design and scope: Program must be comprehensive and ongoing,
or the next day (day 2). Physician’s diagnosis alone is not adequate aiming for patient safety and high-quality care while supporting
without evidence (documented) of symptoms and/or laboratory patient autonomy and choices.
confirmation as required for the specific type of infection. Governance and leadership: Governing board should provide
adequate resources for QAPI efforts, designate one or more persons
Transfer rule: The transfer rule helps to determine responsibility for to be responsible for QAPI, and ensure time, equipment, and
infections. If an infection meets the site-specific criteria on the day of training needed. The board should establish a culture of quality and
transfer or the day after transfer from one inpatient facility to another safety.
inpatient within the same facility or another, or the day of discharge or Feedback, data systems and monitoring: The home collects data,
the day after discharge, the infection is attributed to the monitors services using performance indicators, and reviews
transferring/discharging facility. findings. All adverse events must be investigated when they occur
and action plans implemented.
80% rule: A patient care area is designated according to the type of 4. Performance improvement projects (PIPs): PIPS should be
patient. If 80% of the patients are of a specific type (such as oncology developed to improve care and services.
patients), the CDC location code designates the area accordingly. Systematic analysis and systemic action: The organization
carries out analysis utilizing a structured approach and root cause
analysis with a focus on continuous improvement.
Define the following terms:
Device days, date of the event, and location of attribution.
Sexual harassment is covered under Title VII of the Civil Rights Act Device days: Device days are counted according to the number of
(1964), which prohibits sexual harassment but applies only to patients with a specific device, recorded at the same time each day by
employers with 15 or more employees. Complaints are submitted to the determining how many patients have the device at that time. Device
Equal Employment Opportunity Commission (EEOC). Employers with days are summed at the end of each month. Device days may be
fewer employees are covered by various state laws and regulatory calculated electronically as long as the electronic calculation is within
agencies. Some non-governmental agencies have limited programs to +/- 5 of the manual count.
assist victims of sexual harassment, including the Legal Advocacy Fund
of the AAUW. Sexual abuse and rape are criminal offenses covered by Date of event: The date of event for HAIs is when the last criterion for
laws against sexual violence and involve law enforcement agencies, the event or site-specific infection is met or when a process (such as
insertion of a central line) is completed. Date of event may also be
usually the local police although the federal authorities may intervene in
sex trafficking and online stalking. Many organizations now have referred to as the infection date. For VAE, the date of event is the first
workplace violence prevention programs that include strategies to date when oxygenation worsens.
prevent sexual abuse, stalking, and rape. The National Sexual Assault
Hotline (1-800-656-4673) refers people to the nearest services. The Location of attribution: LOA is the location (facility, unit) to which an
National Sex Offender Public Website [https://www.nsopw.govA links event (such as a surgical site infection) is attributed.
state, tribal, and territorial sexual offender registries. Numerous
organizations provide assistance to victims, including the National
Organization for Victim Assistance.
Discuss regulatory guidance:
Sexual harassment, sexual abuse, and rape.
Sexual harassment is covered under Title VII of the Civil Rights Act Device days: Device days are counted according to the number of
(1964), which prohibits sexual harassment but applies only to patients with a specific device, recorded at the same time each day by
employers with 15 or more employees. Complaints are submitted to the determining how many patients have the device at that time. Device
Equal Employment Opportunity Commission (EEOC). Employers with days are summed at the end of each month. Device days may be
fewer employees are covered by various state laws and regulatory calculated electronically as long as the electronic calculation is within
agencies. Some non-governmental agencies have limited programs to +/- 5 of the manual count.
assist victims of sexual harassment, including the Legal Advocacy Fund
of the AAUW. Sexual abuse and rape are criminal offenses covered by Date of event: The date of event for HAIs is when the last criterion for
laws against sexual violence and involve law enforcement agencies, the event or site-specific infection is met or when a process (such as
insertion of a central line) is completed. Date of event may also be
usually the local police although the federal authorities may intervene in
sex trafficking and online stalking. Many organizations now have referred to as the infection date. For VAE, the date of event is the first
workplace violence prevention programs that include strategies to date when oxygenation worsens.
prevent sexual abuse, stalking, and rape. The National Sexual Assault
Hotline (1-800-656-4673) refers people to the nearest services. The Location of attribution: LOA is the location (facility, unit) to which an
National Sex Offender Public Website [https://www.nsopw.govA links event (such as a surgical site infection) is attributed.
state, tribal, and territorial sexual offender registries. Numerous
organizations provide assistance to victims, including the National
Organization for Victim Assistance.
Discuss regulatory guidance:
Documentation and signature requirements for laboratory services for Medicare providers.
Requirements for blood bank operation include: Documentation requirements for laboratory services for Medicare
• Obtaining a blood bank license and renewing annually. providers include:
• Being available for inspection upon request. • All imaging, laboratory tests, and diagnostic tests must be ordered
• Participating in proficiency testing. by the physician treating the beneficiary.
• Obtaining qualified director and adequate numbers of other • Physician’s progress notes must indicate specifically the tests to be
qualified personnel. performed.
• Supervising staff, identifying training needs, and implementing • Documentation must support the medical necessity of the tests to
training. be performed.
• Having appropriate equipment for all functions. • Records that should be available upon request include progress
• Utilizing appropriate infection control practices and disposing notes, physician’s order/intent to order, laboratory results, and
contaminated materials appropriately. attestation/signature log (for signatures that are illegible).
• Carrying out a documented review for collection/preparation of all
blood components. Signature requirements include:
• Maintaining a manual that outlines all policies and procedures. • Remember that unsigned physician orders/requisitions by
• Maintaining correct and legible records that includes significant themselves do not support intent to order.
steps in procedures, test outcomes, ABO/Rh typing result, and • Physicians should sign all orders for diagnostic services.
donor records, and carrying out reporting responsibilities. • If the physician has failed to sign a progress note that supports
• Establishing criteria for blood collection, processing, storage, intent, the physician must complete and attestation statement and
distribution, and testing. submit it with the response; however, attestation statements are
• Labeling in compliance with Code or Federal Regulations. not acceptable for unsigned physician orders/requisitions.
• Storing blood/blood components appropriately and at correct • Documentation of the order/intent to order and medical necessity
temperature with temperature monitoring system in place. must be maintained in the patient record.
Discuss regulatory guidance: Blood bank operation.
Requirements for blood bank operation include: Documentation requirements for laboratory services for Medicare
• Obtaining a blood bank license and renewing annually. providers include:
• Being available for inspection upon request. • All imaging, laboratory tests, and diagnostic tests must be ordered
• Participating in proficiency testing. by the physician treating the beneficiary.
• Obtaining qualified director and adequate numbers of other • Physician’s progress notes must indicate specifically the tests to be
qualified personnel. performed.
• Supervising staff, identifying training needs, and implementing • Documentation must support the medical necessity of the tests to
training. be performed.
• Having appropriate equipment for all functions. • Records that should be available upon request include progress
• Utilizing appropriate infection control practices and disposing notes, physician’s order/intent to order, laboratory results, and
contaminated materials appropriately. attestation/signature log (for signatures that are illegible).
• Carrying out a documented review for collection/preparation of all
blood components. Signature requirements include:
• Maintaining a manual that outlines all policies and procedures. • Remember that unsigned physician orders/requisitions by
• Maintaining correct and legible records that includes significant themselves do not support intent to order.
steps in procedures, test outcomes, ABO/Rh typing result, and • Physicians should sign all orders for diagnostic services.
donor records, and carrying out reporting responsibilities. • If the physician has failed to sign a progress note that supports
• Establishing criteria for blood collection, processing, storage, intent, the physician must complete and attestation statement and
distribution, and testing. submit it with the response; however, attestation statements are
• Labeling in compliance with Code or Federal Regulations. not acceptable for unsigned physician orders/requisitions.
• Storing blood/blood components appropriately and at correct • Documentation of the order/intent to order and medical necessity
temperature with temperature monitoring system in place. must be maintained in the patient record.
Discuss regulatory guidance:
Computer crossmatch.
Transfusion record documentation must be maintained for at least 5 Under 21 CFR 6096.15 (c), the FDA has established regulations for
years and those required for tracing a blood product from donor to recipient-donor computer crossmatch for transfusions:
disposition maintained for at least 10 years following administration or • User must be able to verify and accept or reject data.
5 years after expiration date. Computerized records must be secure and • Data elements must include the recipient’s unique ID number, RBC
software validated. Records must include all those associated with the antibody screening, ABO/Rh (D) typing, sample, and special
donor, recipient, and blood product, including testing (all steps and transfusion requirements (such as leukoreduction) and the donor’s
results), storage, and disposition. The records must be easily accessible unique identification number, component name, ABO/Rh (D) blood
and allow for tracing of blood products. Donor records must be type, special requirements and RBC antibody screening.
maintained and should include information about storage temperatures • Written procedures should outline decision tables and decision
and visual blood inspections, and preparation of components. Recipient rules.
records should include blood type and information regarding antibodies • The system should provide warning messages when actions are out
history of transfusions, and adverse transfusion reactions. Records of conformance with decision rules.
should also be maintained regarding therapeutic phlebotomy, policies • User validation tests must be run on all new equipment/processes
and procedures, cytapheresis procedures, antibody identification, in the same environment in which they will be utilized and re-
quality control, and shipping. validation carried out according to written program.
• Records must be maintained for all compatibility tests, calibration,
equipment standardization, and performance checks for at least 10
years.
• Implementation of computer crossmatch or change in procedure as
allowed under licensure must be reported to the FDA.
• Unvalidated systems must undergo testing to meet requirements
for validation.
Discuss regulatory guidance: Transfusion administration protocol.
Transfusion record documentation must be maintained for at least 5 Under 21 CFR 6096.15 (c), the FDA has established regulations for
years and those required for tracing a blood product from donor to recipient-donor computer crossmatch for transfusions:
disposition maintained for at least 10 years following administration or • User must be able to verify and accept or reject data.
5 years after expiration date. Computerized records must be secure and • Data elements must include the recipient’s unique ID number, RBC
software validated. Records must include all those associated with the antibody screening, ABO/Rh (D) typing, sample, and special
donor, recipient, and blood product, including testing (all steps and transfusion requirements (such as leukoreduction) and the donor’s
results), storage, and disposition. The records must be easily accessible unique identification number, component name, ABO/Rh (D) blood
and allow for tracing of blood products. Donor records must be type, special requirements and RBC antibody screening.
maintained and should include information about storage temperatures • Written procedures should outline decision tables and decision
and visual blood inspections, and preparation of components. Recipient rules.
records should include blood type and information regarding antibodies • The system should provide warning messages when actions are out
history of transfusions, and adverse transfusion reactions. Records of conformance with decision rules.
should also be maintained regarding therapeutic phlebotomy, policies • User validation tests must be run on all new equipment/processes
and procedures, cytapheresis procedures, antibody identification, in the same environment in which they will be utilized and re-
quality control, and shipping. validation carried out according to written program.
• Records must be maintained for all compatibility tests, calibration,
equipment standardization, and performance checks for at least 10
years.
• Implementation of computer crossmatch or change in procedure as
allowed under licensure must be reported to the FDA.
• Unvalidated systems must undergo testing to meet requirements
for validation.
Discuss regulatory guidance:
Codebar and ISBT numbering systems.
ome communicable diseases pose a danger to healthcare workers The FDA requires that all blood products and materials used for
(HCWs) and to patients and others who have contact with an infected transfusion be labeled with machine-readable labeling language to
healthcare worker. Work restrictions may vary somewhat depending decrease incidence of errors related to the wrong patient or wrong
on state and local regulations. The CDC, OSHA, and ACIP provide some product. The label must contain at least the unique facility ID, the
recommendations, which include: donor’s lot number, the product code, and the blood type of the donor.
• Hepatitis B: HCWs with acute or chronic HB who do not The two labeling languages in use include:
perform exposure-prone procedures are required only to • Codebar: Labeling that includes an identifying barcode, a
always use standard precautions. Those who do perform description of the contents (such as “RED BLOOD CELLS”), the
exposure-prone procedures should be restricted from those volume, additives, storage requirements, and test results of
procedures until a review panel can determine appropriate FDA required tests (such as HIV and HBV.
restrictions. HCWs should be immunized against HBV. • ISB-128: The international standard for identification and
• Influenza: HCWs with influenza should be restricted from labeling as well as transfer of information about body products,
contact with patients and others during the period when the including blood. ISB-128 provides a standard terminology,
disorder is infectious, which usually begins one day prior to reference tables to apply the appropriate codes, data
onset of symptoms (when the person is unaware of the structures, delivery mechanisms, and standard layout for
infection and contagious) and up to 5 days after onset of labels.
symptoms. HCWs should receive annual influenza vaccinations.
Discuss regulatory guidance:
Level of work restriction return to work for health care workers with communicable diseases: hepatitis B, influenza.
ome communicable diseases pose a danger to healthcare workers The FDA requires that all blood products and materials used for
(HCWs) and to patients and others who have contact with an infected transfusion be labeled with machine-readable labeling language to
healthcare worker. Work restrictions may vary somewhat depending decrease incidence of errors related to the wrong patient or wrong
on state and local regulations. The CDC, OSHA, and ACIP provide some product. The label must contain at least the unique facility ID, the
recommendations, which include: donor’s lot number, the product code, and the blood type of the donor.
• Hepatitis B: HCWs with acute or chronic HB who do not The two labeling languages in use include:
perform exposure-prone procedures are required only to • Codebar: Labeling that includes an identifying barcode, a
always use standard precautions. Those who do perform description of the contents (such as “RED BLOOD CELLS”), the
exposure-prone procedures should be restricted from those volume, additives, storage requirements, and test results of
procedures until a review panel can determine appropriate FDA required tests (such as HIV and HBV.
restrictions. HCWs should be immunized against HBV. • ISB-128: The international standard for identification and
• Influenza: HCWs with influenza should be restricted from labeling as well as transfer of information about body products,
contact with patients and others during the period when the including blood. ISB-128 provides a standard terminology,
disorder is infectious, which usually begins one day prior to reference tables to apply the appropriate codes, data
onset of symptoms (when the person is unaware of the structures, delivery mechanisms, and standard layout for
infection and contagious) and up to 5 days after onset of labels.
symptoms. HCWs should receive annual influenza vaccinations.
Discuss regulatory guidance:
Level of work restriction/return to work for health care workers with communicable diseases: measles, mumps, rubella, and varicella.
Legal requirements for documenting wounds are often quite general, Work restrictions for healthcare workers (HCWs) with communicable
requiring that documentation be “timely and accurate” without diseases may vary somewhat depending on state and local regulations.
specifying exactly what that entails. However, CMS reimbursement is The CDC, OSHA, and ACIP provide some recommendations, which
predicated on documented information, so correct documentation has, include:
in effect, become a legal requirement. Considerations include: • Measles: Active disease requires restriction from duty until 7
• Coding forsupplies utilized for wound care must be correct. days after onset of rash and with exposure restriction from
• Wounds must be coded properly as traumatic or nontraumatic. duty from the 5th days through the 21st day after exposure
• Debridement must be specified as excisional or nonexcisional. and/or 4 days after onset of rash.
_ • Laboratory and imaging reports and nutritional assessments • Mumps: Active disease requires restriction from duty until 9
that support wound care must be in the patient’s health record. days after onset of parotitis and with exposure restriction from
• Wound size and stage must be documented in order to duty from the 9th through the 26th day after exposure or until 9
determine the patient’s acuity level. days after onset of parotitis.
• • Skin condition must be documented on admission, including • • Rubella: Active disease requires restriction from duty until 5
any wounds that are present or lack of wounds. days after onset of rash and with exposure restriction from the
General rules for charting should also be followed, including recording 7th through the 21st day after exposure.
the date and time of all entries, using accurate measurements, providing • Varicella: Active disease requires restriction from duty until
factual objective information, and using only approved abbreviations in all lesions are dry and crusted and with exposure restriction
order to prevent errors. from duty from the 10th through the 21st (or 28th if VZIG given)
day or until all lesions are dry and crusted if active disease
occurs.
Discuss regulatory guidance:
Documenting wounds.
Legal requirements for documenting wounds are often quite general, Work restrictions for healthcare workers (HCWs) with communicable
requiring that documentation be “timely and accurate” without diseases may vary somewhat depending on state and local regulations.
specifying exactly what that entails. However, CMS reimbursement is The CDC, OSHA, and ACIP provide some recommendations, which
predicated on documented information, so correct documentation has, include:
in effect, become a legal requirement. Considerations include: • Measles: Active disease requires restriction from duty until 7
• Coding forsupplies utilized for wound care must be correct. days after onset of rash and with exposure restriction from
• Wounds must be coded properly as traumatic or nontraumatic. duty from the 5th days through the 21st day after exposure
• Debridement must be specified as excisional or nonexcisional. and/or 4 days after onset of rash.
_ • Laboratory and imaging reports and nutritional assessments • Mumps: Active disease requires restriction from duty until 9
that support wound care must be in the patient’s health record. days after onset of parotitis and with exposure restriction from
• Wound size and stage must be documented in order to duty from the 9th through the 26th day after exposure or until 9
determine the patient’s acuity level. days after onset of parotitis.
• • Skin condition must be documented on admission, including • • Rubella: Active disease requires restriction from duty until 5
any wounds that are present or lack of wounds. days after onset of rash and with exposure restriction from the
General rules for charting should also be followed, including recording 7th through the 21st day after exposure.
the date and time of all entries, using accurate measurements, providing • Varicella: Active disease requires restriction from duty until
factual objective information, and using only approved abbreviations in all lesions are dry and crusted and with exposure restriction
order to prevent errors. from duty from the 10th through the 21st (or 28th if VZIG given)
day or until all lesions are dry and crusted if active disease
occurs.
Discuss regulatory guidance:
Equipment safety including sharps receptacle for needle disposal.
The United States Pharmacopeia (USP) guidelines to prevent Under the Needlestick Safety and Prevention Act, equipment safety is
prescription and transcribing errors includes: essential because lancets, needles, and other sharp objects pose risks to
• Submitting order electronically and avoiding handwritten laboratory personnel and must be used properly and disposed of safely
transcriptions which can more easily be misread or misinterpreted. in specific (“sharps”) containers designed for safety. Procedures should
• Prescribing only standardized concentrations of intravenous infusions,
such as D5W. be in place for all use of sharps and standard precautions followed.
• Establishing clear protocols for intravenous infusions. Safety lancets with needles that automatically retract should be utilized
• Avoiding the use of unclear abbreviations, such as those on the Joint if possible. Safety needles are also available; but, if using a standard
Commissions do-not-use list. needle, the needle should not be recapped or bent prior to disposal but
• Transcribing original drug orders should be done as soon as possible placed directly into the container, sharp end downward. Sharps
after receiving the order with minimal interruptions and should be containers should be leak-proof, resistant to punctures, clearly labeled,
and placed in a convenient place not accessible by children. Most sharps
verified by another person for accuracy. Digital transcription is safer
than manual. containers are red, but clear containers may also be used so it is easier
to see when they are full. Containers should never be filled to the top
Guidelines to prevent dispensing errors include: because of the risk that a needle or other sharp item may protrude
• Stocking and preparing standardized concentrations for all IV through the opening.
medications.
• Properly labeling intravenous solution bags with completed patient
name, product name, product dosage, final concentration, and infusion
rate (if appropriate).
• Utilizing commercially prepared solutions as much as possible and
limited the use of different dosages/strengths of the same medication
or solution.
Discuss regulatory guidance:
The United States Pharmacopeia guidelines to prevent prescription and transcribing errors and dispensing errors.
The United States Pharmacopeia (USP) guidelines to prevent Under the Needlestick Safety and Prevention Act, equipment safety is
prescription and transcribing errors includes: essential because lancets, needles, and other sharp objects pose risks to
• Submitting order electronically and avoiding handwritten laboratory personnel and must be used properly and disposed of safely
transcriptions which can more easily be misread or misinterpreted. in specific (“sharps”) containers designed for safety. Procedures should
• Prescribing only standardized concentrations of intravenous infusions,
such as D5W. be in place for all use of sharps and standard precautions followed.
• Establishing clear protocols for intravenous infusions. Safety lancets with needles that automatically retract should be utilized
• Avoiding the use of unclear abbreviations, such as those on the Joint if possible. Safety needles are also available; but, if using a standard
Commissions do-not-use list. needle, the needle should not be recapped or bent prior to disposal but
• Transcribing original drug orders should be done as soon as possible placed directly into the container, sharp end downward. Sharps
after receiving the order with minimal interruptions and should be containers should be leak-proof, resistant to punctures, clearly labeled,
and placed in a convenient place not accessible by children. Most sharps
verified by another person for accuracy. Digital transcription is safer
than manual. containers are red, but clear containers may also be used so it is easier
to see when they are full. Containers should never be filled to the top
Guidelines to prevent dispensing errors include: because of the risk that a needle or other sharp item may protrude
• Stocking and preparing standardized concentrations for all IV through the opening.
medications.
• Properly labeling intravenous solution bags with completed patient
name, product name, product dosage, final concentration, and infusion
rate (if appropriate).
• Utilizing commercially prepared solutions as much as possible and
limited the use of different dosages/strengths of the same medication
or solution.
Discuss regulatory guidance:
United States Pharmacopeia guidelines to prevent drug administration and monitoring errors.
According to the Patient Self-Determination Act (1990) competent The United States Pharmacopeia guidelines to prevent drug
patients have the right to refusal of care, and parents have the right to administration and monitoring errors include:
make this decision for minor children. The act also allows a mental • Being familiar with policies and procedures regarding drug
health patient to develop an advance psychiatric directive (APD) during administration.
a period when a professional mental healthcare provider certifies the • Having readily accessible standardized infusion rate charts.
person is of sound mind. If a patient refuses care, the healthcare • Utilizing programmable infusion devices, such as smart pumps.
provider should try to persuade the patient to agree to care by giving the
reasons and possible consequences of refusal. The patient should be • Standardizing equipment rather than having multiple models and
asked to sign the refusal form and a family member, police officer, or types.
• Ensuring that two qualified individuals independently confirm
bystander should sign as a witness to the patient’s signing or witness the infusion pump setting for high-risk/high-alert drugs and required
refusal to sign. The healthcare provider should complete documentation adjustments in dosage.
of any assessment carried out and any refusal of the patient to • Ensuring that documentation is correct and provides adequate
assessment. The healthcare provider should carefully document the information, including the name of the drug, the infusion rate, any
conversation between the healthcare provider and patient regarding adjustments, and names of those who confirmed dosage/setting.
refusaLof care and consequences and should document the proposed • Tracing infusion tubing from the solution bags to the insertion sites
care as well as the information the healthcare provider gave the patient and clearly labeling tubes when multiple infusions/pumps. This is
about alternate care (such as visit to personal physician) and the especially important if adding medications to an infusion.
willingness to return if the patient has a change of mind. • Avoiding free-flow errors, such as through anti-free-flow devices.
• Monitoring the patient’s response to the medication according to
standardizes critical pathways or flow sheets.
Discuss regulatory guidance:
Patient Self-Determination Act and the right to refusal of care.
According to the Patient Self-Determination Act (1990) competent The United States Pharmacopeia guidelines to prevent drug
patients have the right to refusal of care, and parents have the right to administration and monitoring errors include:
make this decision for minor children. The act also allows a mental • Being familiar with policies and procedures regarding drug
health patient to develop an advance psychiatric directive (APD) during administration.
a period when a professional mental healthcare provider certifies the • Having readily accessible standardized infusion rate charts.
person is of sound mind. If a patient refuses care, the healthcare • Utilizing programmable infusion devices, such as smart pumps.
provider should try to persuade the patient to agree to care by giving the
reasons and possible consequences of refusal. The patient should be • Standardizing equipment rather than having multiple models and
asked to sign the refusal form and a family member, police officer, or types.
• Ensuring that two qualified individuals independently confirm
bystander should sign as a witness to the patient’s signing or witness the infusion pump setting for high-risk/high-alert drugs and required
refusal to sign. The healthcare provider should complete documentation adjustments in dosage.
of any assessment carried out and any refusal of the patient to • Ensuring that documentation is correct and provides adequate
assessment. The healthcare provider should carefully document the information, including the name of the drug, the infusion rate, any
conversation between the healthcare provider and patient regarding adjustments, and names of those who confirmed dosage/setting.
refusaLof care and consequences and should document the proposed • Tracing infusion tubing from the solution bags to the insertion sites
care as well as the information the healthcare provider gave the patient and clearly labeling tubes when multiple infusions/pumps. This is
about alternate care (such as visit to personal physician) and the especially important if adding medications to an infusion.
willingness to return if the patient has a change of mind. • Avoiding free-flow errors, such as through anti-free-flow devices.
• Monitoring the patient’s response to the medication according to
standardizes critical pathways or flow sheets.
Discuss workforce education:
Compliance training as part of new employee orientation.
Temporary, per diem, and contract employees as well as students Compliance training, including the Code of Conduct, should be part of
and volunteers can pose complex challenges related to compliance new employee orientation so that the employee has an understanding
issues because these individuals must have training in compliance and of the importance of compliance at the outset. Because the time given to
privacy either through the organization or the agency that provides the compliance during orientation is generally limited, the compliance
individuals. These individuals may not be hired through Human professional should focus on key information. Orientation should
Resources but through contractual agreements. Thus, the contracts include:
should be assessed to ensure that compliance training is included. • General overview of compliance, including information about the
Students can pose particular problems because their levels of knowledge roles of the compliance professional and the compliance committee.
and training may vary widely. Training that is to be provided by other • Code of conduct and how it applies to compliance, such as through
agencies should be verified but many different contractual ethical conduct; accurate documentation, coding, and billing;
arrangements may be present in one organization, so this can be time privacy and confidentiality; fraudulent and abusive actions;
consuming and involve multiple contacts. Additionally, if an organization exclusions; and conflicts of interest.
utilizes volunteers, the compliance professional should monitor • Explanation of sanctions/disciplinary policies.
background checks and appropriate compliance training. • Discussion of mechanisms available to share concerns (such as a
hotline).
• Provide clear explanation of where to go and whom to approach if
they have questions about compliance or other issues.
Participants are more likely to remember information if there is some
interactivity included, such as questioning or discussions, and the
information should be tied to real-life examples as much as possible.